nodes	percent_of_prediction	percent_of_DWPC	metapath
Rasagiline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.108	0.456	CbGbCtD
Rasagiline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0866	0.365	CbGbCtD
Rasagiline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0424	0.179	CbGbCtD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—PPP3R1—peripheral nervous system neoplasm	0.0104	0.0553	CbGpPWpGaD
Rasagiline—MAOB—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.00822	0.0439	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00736	0.0393	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—PPP3R1—peripheral nervous system neoplasm	0.00688	0.0368	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TNFSF10—peripheral nervous system neoplasm	0.00619	0.0331	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—PPP3R1—peripheral nervous system neoplasm	0.00492	0.0263	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—GNAS—peripheral nervous system neoplasm	0.00413	0.0221	CbGpPWpGaD
Rasagiline—MAOB—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.0041	0.0219	CbGpPWpGaD
Rasagiline—BCL2—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.00359	0.0192	CbGpPWpGaD
Rasagiline—BCL2—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.00308	0.179	CbGdCrCtD
Rasagiline—BCL2—Integrated Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.00294	0.0157	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—CDKN2A—peripheral nervous system neoplasm	0.00276	0.0148	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—BARD1—peripheral nervous system neoplasm	0.00274	0.0147	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CD34—peripheral nervous system neoplasm	0.00271	0.0145	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—TNFSF10—peripheral nervous system neoplasm	0.00257	0.0137	CbGpPWpGaD
Rasagiline—BCL2—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00257	0.149	CbGdCrCtD
Rasagiline—BCL2—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.149	CbGdCrCtD
Rasagiline—BCL2—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00257	0.149	CbGdCrCtD
Rasagiline—BCL2—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00257	0.149	CbGdCrCtD
Rasagiline—BCL2—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.00238	0.0127	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—PTPN11—peripheral nervous system neoplasm	0.00232	0.0124	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—PTPN11—peripheral nervous system neoplasm	0.0022	0.0118	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—BIRC5—peripheral nervous system neoplasm	0.00213	0.0114	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—PTPN11—peripheral nervous system neoplasm	0.00196	0.0105	CbGpPWpGaD
Rasagiline—BCL2—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.113	CbGdCrCtD
Rasagiline—BCL2—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00195	0.113	CbGdCrCtD
Rasagiline—BCL2—Apoptosis—TNFSF10—peripheral nervous system neoplasm	0.00189	0.0101	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—MYC—peripheral nervous system neoplasm	0.00187	0.01	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00185	0.00991	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00184	0.00986	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00177	0.00948	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TNFSF10—peripheral nervous system neoplasm	0.00177	0.00946	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00171	0.00913	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—NF1—peripheral nervous system neoplasm	0.0017	0.00906	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—PPP3R1—peripheral nervous system neoplasm	0.0016	0.00854	CbGpPWpGaD
Rasagiline—BCL2—Activation of BAD and translocation to mitochondria—AKT1—peripheral nervous system neoplasm	0.00157	0.00839	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—PTPN11—peripheral nervous system neoplasm	0.00157	0.00838	CbGpPWpGaD
Rasagiline—BCL2—HIV-1 Nef: Negative effector of Fas and TNF-alpha—CASP3—peripheral nervous system neoplasm	0.00154	0.00825	CbGpPWpGaD
Rasagiline—BCL2—TP53 Network—TP53—peripheral nervous system neoplasm	0.00154	0.00822	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—PTPN11—peripheral nervous system neoplasm	0.00152	0.00812	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—IFNB1—peripheral nervous system neoplasm	0.00151	0.00809	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—PTPN11—peripheral nervous system neoplasm	0.00145	0.00775	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—CASP3—peripheral nervous system neoplasm	0.00138	0.00737	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—CASP3—peripheral nervous system neoplasm	0.00138	0.00737	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—GNAS—peripheral nervous system neoplasm	0.00136	0.00728	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00135	0.00722	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by STAT5—MYC—peripheral nervous system neoplasm	0.0013	0.00695	CbGpPWpGaD
Rasagiline—BCL2—FAS pathway and Stress induction of HSP regulation—CASP3—peripheral nervous system neoplasm	0.00127	0.0068	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—BIRC5—peripheral nervous system neoplasm	0.00127	0.00679	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—TP53—peripheral nervous system neoplasm	0.00124	0.0066	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AURKA—peripheral nervous system neoplasm	0.00123	0.00655	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.00123	0.00655	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—BIRC5—peripheral nervous system neoplasm	0.00119	0.00637	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TNFSF10—peripheral nervous system neoplasm	0.00116	0.00618	CbGpPWpGaD
Rasagiline—BCL2—Estrogen signaling pathway—AKT1—peripheral nervous system neoplasm	0.00111	0.00596	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—MYC—peripheral nervous system neoplasm	0.0011	0.00588	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.0011	0.00586	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.00105	0.00559	CbGpPWpGaD
Rasagiline—BCL2—Activation of BH3-only proteins—AKT1—peripheral nervous system neoplasm	0.00104	0.00558	CbGpPWpGaD
Rasagiline—BCL2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—CASP3—peripheral nervous system neoplasm	0.00104	0.00556	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—MYC—peripheral nervous system neoplasm	0.00103	0.00552	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—ERBB2—peripheral nervous system neoplasm	0.00101	0.00542	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—CASP3—peripheral nervous system neoplasm	0.000996	0.00533	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—MYC—peripheral nervous system neoplasm	0.000993	0.00531	CbGpPWpGaD
Rasagiline—BCL2—EPO signaling pathway—HRAS—peripheral nervous system neoplasm	0.00097	0.00518	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000957	0.00511	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—HGF—peripheral nervous system neoplasm	0.000928	0.00496	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000908	0.00485	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—MYC—peripheral nervous system neoplasm	0.000892	0.00477	CbGpPWpGaD
Rasagiline—BCL2—Amyotrophic lateral sclerosis (ALS)—TP53—peripheral nervous system neoplasm	0.000884	0.00472	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—TP53—peripheral nervous system neoplasm	0.000884	0.00472	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—NRAS—peripheral nervous system neoplasm	0.000872	0.00466	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CDKN2A—peripheral nervous system neoplasm	0.000842	0.0045	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000842	0.0045	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.000828	0.00443	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—MYC—peripheral nervous system neoplasm	0.000812	0.00434	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CDKN2A—peripheral nervous system neoplasm	0.000789	0.00422	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000786	0.0042	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.00078	0.00417	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—CD55—peripheral nervous system neoplasm	0.000765	0.00409	CbGpPWpGaD
Rasagiline—BCL2—IL2 signaling events mediated by PI3K—AKT1—peripheral nervous system neoplasm	0.000762	0.00407	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000758	0.00405	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000758	0.00405	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000751	0.00402	CbGpPWpGaD
Rasagiline—BCL2—Intrinsic Pathway for Apoptosis—AKT1—peripheral nervous system neoplasm	0.000746	0.00399	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000745	0.00398	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—MET—peripheral nervous system neoplasm	0.000732	0.00391	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—peripheral nervous system neoplasm	0.000731	0.00391	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HGF—peripheral nervous system neoplasm	0.000727	0.00388	CbGpPWpGaD
Rasagiline—BCL2—Validated targets of C-MYC transcriptional repression—MYC—peripheral nervous system neoplasm	0.000718	0.00384	CbGpPWpGaD
Rasagiline—BCL2—IL-5 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000716	0.00383	CbGpPWpGaD
Rasagiline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000706	0.00378	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—CDKN2A—peripheral nervous system neoplasm	0.000704	0.00376	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000689	0.00369	CbGpPWpGaD
Rasagiline—BCL2—IL-2 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000689	0.00368	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—CASP3—peripheral nervous system neoplasm	0.000685	0.00366	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—CDKN2A—peripheral nervous system neoplasm	0.000683	0.00365	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—CASP3—peripheral nervous system neoplasm	0.000679	0.00363	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—HRAS—peripheral nervous system neoplasm	0.000668	0.00357	CbGpPWpGaD
Rasagiline—BCL2—Interleukin-11 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000664	0.00355	CbGpPWpGaD
Rasagiline—BCL2—Integrated Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000664	0.00355	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—ERBB2—peripheral nervous system neoplasm	0.000653	0.00349	CbGpPWpGaD
Rasagiline—BCL2—IL2-mediated signaling events—HRAS—peripheral nervous system neoplasm	0.000638	0.00341	CbGpPWpGaD
Rasagiline—BCL2—Ceramide signaling pathway—AKT1—peripheral nervous system neoplasm	0.000619	0.00331	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—NRAS—peripheral nervous system neoplasm	0.000612	0.00327	CbGpPWpGaD
Rasagiline—BCL2—IL-3 Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000609	0.00325	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—HRAS—peripheral nervous system neoplasm	0.000594	0.00318	CbGpPWpGaD
Rasagiline—BCL2—Signaling events mediated by Stem cell factor receptor (c-Kit)—AKT1—peripheral nervous system neoplasm	0.00059	0.00315	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—MET—peripheral nervous system neoplasm	0.000573	0.00306	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—MYC—peripheral nervous system neoplasm	0.00057	0.00305	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—MYC—peripheral nervous system neoplasm	0.00057	0.00305	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—PPP3R1—peripheral nervous system neoplasm	0.000558	0.00298	CbGpPWpGaD
Rasagiline—BCL2—Caspase Cascade in Apoptosis—AKT1—peripheral nervous system neoplasm	0.000539	0.00288	CbGpPWpGaD
Rasagiline—BCL2—Kit receptor signaling pathway—AKT1—peripheral nervous system neoplasm	0.000525	0.00281	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000512	0.00274	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—NRAS—peripheral nervous system neoplasm	0.000497	0.00266	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—peripheral nervous system neoplasm	0.000468	0.0025	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—MYC—peripheral nervous system neoplasm	0.000463	0.00248	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000457	0.00244	CbGpPWpGaD
Rasagiline—BCL2—C-MYB transcription factor network—HRAS—peripheral nervous system neoplasm	0.000448	0.00239	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—CASP3—peripheral nervous system neoplasm	0.000448	0.00239	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD55—peripheral nervous system neoplasm	0.000446	0.00238	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis Modulation and Signaling—TP53—peripheral nervous system neoplasm	0.000439	0.00235	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—ERBB2—peripheral nervous system neoplasm	0.000419	0.00224	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000417	0.00223	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000396	0.00211	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	0.000392	0.00209	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—IFNB1—peripheral nervous system neoplasm	0.000387	0.00207	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—TP53—peripheral nervous system neoplasm	0.00038	0.00203	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000379	0.00202	CbGpPWpGaD
Rasagiline—BCL2—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	0.000375	0.002	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—GNS—peripheral nervous system neoplasm	0.00037	0.00198	CbGpPWpGaD
Rasagiline—BCL2—Corticotropin-releasing hormone—AKT1—peripheral nervous system neoplasm	0.000368	0.00197	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—HRAS—peripheral nervous system neoplasm	0.000364	0.00194	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000357	0.00191	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—NME1—peripheral nervous system neoplasm	0.000355	0.0019	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—COX2—peripheral nervous system neoplasm	0.000342	0.00183	CbGpPWpGaD
Rasagiline—BCL2—Immune System—CD34—peripheral nervous system neoplasm	0.000338	0.00181	CbGpPWpGaD
Rasagiline—BCL2—Immune System—PPP3R1—peripheral nervous system neoplasm	0.000325	0.00174	CbGpPWpGaD
Rasagiline—BCL2—DNA Damage Response (only ATM dependent)—AKT1—peripheral nervous system neoplasm	0.000321	0.00172	CbGpPWpGaD
Rasagiline—BCL2—Direct p53 effectors—TP53—peripheral nervous system neoplasm	0.000311	0.00166	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000296	0.00158	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000293	0.00157	CbGpPWpGaD
Rasagiline—BCL2—Immune System—NCAM1—peripheral nervous system neoplasm	0.000287	0.00154	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—TP53—peripheral nervous system neoplasm	0.000287	0.00153	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000266	0.00142	CbGpPWpGaD
Rasagiline—BCL2—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000247	0.00132	CbGpPWpGaD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000243	0.0013	CbGpPWpGaD
Rasagiline—BCL2—Apoptosis—AKT1—peripheral nervous system neoplasm	0.000242	0.0013	CbGpPWpGaD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	0.000236	0.00126	CbGpPWpGaD
Rasagiline—BCL2—Focal Adhesion—HRAS—peripheral nervous system neoplasm	0.000233	0.00125	CbGpPWpGaD
Rasagiline—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000233	0.000418	CcSEcCtD
Rasagiline—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000233	0.000418	CcSEcCtD
Rasagiline—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000416	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000231	0.000414	CcSEcCtD
Rasagiline—Infection—Etoposide—peripheral nervous system neoplasm	0.000231	0.000413	CcSEcCtD
Rasagiline—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000413	CcSEcCtD
Rasagiline—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.000412	CcSEcCtD
Rasagiline—Nausea—Melphalan—peripheral nervous system neoplasm	0.00023	0.000412	CcSEcCtD
Rasagiline—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00041	CcSEcCtD
Rasagiline—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00041	CcSEcCtD
Rasagiline—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000229	0.00041	CcSEcCtD
Rasagiline—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000228	0.000408	CcSEcCtD
Rasagiline—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000227	0.000406	CcSEcCtD
Rasagiline—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000227	0.000406	CcSEcCtD
Rasagiline—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000405	CcSEcCtD
Rasagiline—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000226	0.000405	CcSEcCtD
Rasagiline—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000225	0.000404	CcSEcCtD
Rasagiline—BCL2—Immune System—IFNB1—peripheral nervous system neoplasm	0.000225	0.0012	CbGpPWpGaD
Rasagiline—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000224	0.000402	CcSEcCtD
Rasagiline—MAOB—Metabolism—ENO2—peripheral nervous system neoplasm	0.000224	0.0012	CbGpPWpGaD
Rasagiline—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000401	CcSEcCtD
Rasagiline—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000399	CcSEcCtD
Rasagiline—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000221	0.000396	CcSEcCtD
Rasagiline—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000395	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	0.00022	0.00118	CbGpPWpGaD
Rasagiline—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000219	0.000393	CcSEcCtD
Rasagiline—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000219	0.000393	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000219	0.000392	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—PTPN11—peripheral nervous system neoplasm	0.000218	0.00117	CbGpPWpGaD
Rasagiline—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000217	0.000389	CcSEcCtD
Rasagiline—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000387	CcSEcCtD
Rasagiline—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000214	0.000383	CcSEcCtD
Rasagiline—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000213	0.000382	CcSEcCtD
Rasagiline—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000213	0.000381	CcSEcCtD
Rasagiline—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000379	CcSEcCtD
Rasagiline—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000379	CcSEcCtD
Rasagiline—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000379	CcSEcCtD
Rasagiline—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000379	CcSEcCtD
Rasagiline—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000211	0.000378	CcSEcCtD
Rasagiline—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.000377	CcSEcCtD
Rasagiline—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000374	CcSEcCtD
Rasagiline—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000209	0.000374	CcSEcCtD
Rasagiline—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000208	0.000373	CcSEcCtD
Rasagiline—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000207	0.000371	CcSEcCtD
Rasagiline—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000207	0.000371	CcSEcCtD
Rasagiline—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000206	0.00037	CcSEcCtD
Rasagiline—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000369	CcSEcCtD
Rasagiline—BCL2—Focal Adhesion—AKT1—peripheral nervous system neoplasm	0.000206	0.0011	CbGpPWpGaD
Rasagiline—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000206	0.000368	CcSEcCtD
Rasagiline—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000205	0.0011	CbGpPWpGaD
Rasagiline—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000365	CcSEcCtD
Rasagiline—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000204	0.000365	CcSEcCtD
Rasagiline—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000204	0.000365	CcSEcCtD
Rasagiline—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.000365	CcSEcCtD
Rasagiline—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000202	0.000362	CcSEcCtD
Rasagiline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000202	0.000362	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.0002	0.000359	CcSEcCtD
Rasagiline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0002	0.000359	CcSEcCtD
Rasagiline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000358	CcSEcCtD
Rasagiline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000356	CcSEcCtD
Rasagiline—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000199	0.000356	CcSEcCtD
Rasagiline—Constipation—Etoposide—peripheral nervous system neoplasm	0.000199	0.000356	CcSEcCtD
Rasagiline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000198	0.000355	CcSEcCtD
Rasagiline—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.000355	CcSEcCtD
Rasagiline—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.000353	CcSEcCtD
Rasagiline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000197	0.000352	CcSEcCtD
Rasagiline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000196	0.000351	CcSEcCtD
Rasagiline—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000196	0.00035	CcSEcCtD
Rasagiline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.00035	CcSEcCtD
Rasagiline—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000348	CcSEcCtD
Rasagiline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000346	CcSEcCtD
Rasagiline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000345	CcSEcCtD
Rasagiline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000343	CcSEcCtD
Rasagiline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000191	0.000343	CcSEcCtD
Rasagiline—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000191	0.000341	CcSEcCtD
Rasagiline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00019	0.00034	CcSEcCtD
Rasagiline—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00019	0.000339	CcSEcCtD
Rasagiline—MAOB—Metabolism—BCHE—peripheral nervous system neoplasm	0.000189	0.00101	CbGpPWpGaD
Rasagiline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000189	0.000339	CcSEcCtD
Rasagiline—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000338	CcSEcCtD
Rasagiline—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000189	0.000338	CcSEcCtD
Rasagiline—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000336	CcSEcCtD
Rasagiline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000336	CcSEcCtD
Rasagiline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000187	0.000334	CcSEcCtD
Rasagiline—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000334	CcSEcCtD
Rasagiline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000332	CcSEcCtD
Rasagiline—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000184	0.00033	CcSEcCtD
Rasagiline—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000184	0.00033	CcSEcCtD
Rasagiline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00033	CcSEcCtD
Rasagiline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00033	CcSEcCtD
Rasagiline—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000329	CcSEcCtD
Rasagiline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000184	0.000329	CcSEcCtD
Rasagiline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000184	0.000329	CcSEcCtD
Rasagiline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.000329	CcSEcCtD
Rasagiline—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000183	0.000328	CcSEcCtD
Rasagiline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000326	CcSEcCtD
Rasagiline—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000182	0.000326	CcSEcCtD
Rasagiline—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000326	CcSEcCtD
Rasagiline—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000324	CcSEcCtD
Rasagiline—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000181	0.000324	CcSEcCtD
Rasagiline—MAOB—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000181	0.000966	CbGpPWpGaD
Rasagiline—Rash—Vincristine—peripheral nervous system neoplasm	0.000181	0.000324	CcSEcCtD
Rasagiline—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000181	0.000323	CcSEcCtD
Rasagiline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000323	CcSEcCtD
Rasagiline—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000322	CcSEcCtD
Rasagiline—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000322	CcSEcCtD
Rasagiline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000322	CcSEcCtD
Rasagiline—Headache—Vincristine—peripheral nervous system neoplasm	0.00018	0.000322	CcSEcCtD
Rasagiline—MAOB—Metabolism—TH—peripheral nervous system neoplasm	0.000178	0.000952	CbGpPWpGaD
Rasagiline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000319	CcSEcCtD
Rasagiline—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000177	0.000316	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000175	0.000937	CbGpPWpGaD
Rasagiline—BCL2—Immune System—HGF—peripheral nervous system neoplasm	0.000174	0.00093	CbGpPWpGaD
Rasagiline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000311	CcSEcCtD
Rasagiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	0.000173	0.000924	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—ERBB2—peripheral nervous system neoplasm	0.000172	0.000921	CbGpPWpGaD
Rasagiline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000307	CcSEcCtD
Rasagiline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000171	0.000306	CcSEcCtD
Rasagiline—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000305	CcSEcCtD
Rasagiline—Nausea—Vincristine—peripheral nervous system neoplasm	0.00017	0.000305	CcSEcCtD
Rasagiline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000305	CcSEcCtD
Rasagiline—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000304	CcSEcCtD
Rasagiline—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000304	CcSEcCtD
Rasagiline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000169	0.000302	CcSEcCtD
Rasagiline—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.0003	CcSEcCtD
Rasagiline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000299	CcSEcCtD
Rasagiline—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000167	0.000298	CcSEcCtD
Rasagiline—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000167	0.000298	CcSEcCtD
Rasagiline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000298	CcSEcCtD
Rasagiline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000298	CcSEcCtD
Rasagiline—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000296	CcSEcCtD
Rasagiline—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000165	0.000296	CcSEcCtD
Rasagiline—Chills—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000294	CcSEcCtD
Rasagiline—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000164	0.000294	CcSEcCtD
Rasagiline—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.00029	CcSEcCtD
Rasagiline—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000161	0.000289	CcSEcCtD
Rasagiline—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000287	CcSEcCtD
Rasagiline—Rash—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000286	CcSEcCtD
Rasagiline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000286	CcSEcCtD
Rasagiline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000286	CcSEcCtD
Rasagiline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000159	0.000285	CcSEcCtD
Rasagiline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000284	CcSEcCtD
Rasagiline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000157	0.000282	CcSEcCtD
Rasagiline—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000281	CcSEcCtD
Rasagiline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000156	0.00028	CcSEcCtD
Rasagiline—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000154	0.000276	CcSEcCtD
Rasagiline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000275	CcSEcCtD
Rasagiline—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000154	0.000275	CcSEcCtD
Rasagiline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000275	CcSEcCtD
Rasagiline—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000274	CcSEcCtD
Rasagiline—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000274	CcSEcCtD
Rasagiline—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000152	0.000272	CcSEcCtD
Rasagiline—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000151	0.00027	CcSEcCtD
Rasagiline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000268	CcSEcCtD
Rasagiline—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000266	CcSEcCtD
Rasagiline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000265	CcSEcCtD
Rasagiline—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000148	0.000264	CcSEcCtD
Rasagiline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000264	CcSEcCtD
Rasagiline—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000264	CcSEcCtD
Rasagiline—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000262	CcSEcCtD
Rasagiline—Rash—Etoposide—peripheral nervous system neoplasm	0.000146	0.000262	CcSEcCtD
Rasagiline—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000146	0.000262	CcSEcCtD
Rasagiline—Headache—Etoposide—peripheral nervous system neoplasm	0.000145	0.000261	CcSEcCtD
Rasagiline—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	0.000145	0.000777	CbGpPWpGaD
Rasagiline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.00026	CcSEcCtD
Rasagiline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000144	0.000259	CcSEcCtD
Rasagiline—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000258	CcSEcCtD
Rasagiline—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000257	CcSEcCtD
Rasagiline—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000256	CcSEcCtD
Rasagiline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000256	CcSEcCtD
Rasagiline—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000256	CcSEcCtD
Rasagiline—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000143	0.000763	CbGpPWpGaD
Rasagiline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000254	CcSEcCtD
Rasagiline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000251	CcSEcCtD
Rasagiline—Cough—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000249	CcSEcCtD
Rasagiline—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000247	CcSEcCtD
Rasagiline—Nausea—Etoposide—peripheral nervous system neoplasm	0.000138	0.000247	CcSEcCtD
Rasagiline—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000138	0.000247	CcSEcCtD
Rasagiline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000245	CcSEcCtD
Rasagiline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000244	CcSEcCtD
Rasagiline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000243	CcSEcCtD
Rasagiline—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000243	CcSEcCtD
Rasagiline—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000243	CcSEcCtD
Rasagiline—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000242	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000241	CcSEcCtD
Rasagiline—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000134	0.00024	CcSEcCtD
Rasagiline—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000238	CcSEcCtD
Rasagiline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000133	0.000238	CcSEcCtD
Rasagiline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000237	CcSEcCtD
Rasagiline—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000237	CcSEcCtD
Rasagiline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000237	CcSEcCtD
Rasagiline—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000235	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—NRAS—peripheral nervous system neoplasm	0.000131	0.000701	CbGpPWpGaD
Rasagiline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000232	CcSEcCtD
Rasagiline—Infection—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000232	CcSEcCtD
Rasagiline—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000231	CcSEcCtD
Rasagiline—Shock—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000229	CcSEcCtD
Rasagiline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000229	CcSEcCtD
Rasagiline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000229	CcSEcCtD
Rasagiline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000228	CcSEcCtD
Rasagiline—BCL2—Immune System—PTPN11—peripheral nervous system neoplasm	0.000127	0.000679	CbGpPWpGaD
Rasagiline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000226	CcSEcCtD
Rasagiline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000225	CcSEcCtD
Rasagiline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000225	CcSEcCtD
Rasagiline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000225	CcSEcCtD
Rasagiline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000224	CcSEcCtD
Rasagiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000223	CcSEcCtD
Rasagiline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000222	CcSEcCtD
Rasagiline—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000222	CcSEcCtD
Rasagiline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.00022	CcSEcCtD
Rasagiline—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000218	CcSEcCtD
Rasagiline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000217	CcSEcCtD
Rasagiline—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000214	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000212	CcSEcCtD
Rasagiline—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000212	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000118	0.000633	CbGpPWpGaD
Rasagiline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000212	CcSEcCtD
Rasagiline—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000211	CcSEcCtD
Rasagiline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00021	CcSEcCtD
Rasagiline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000209	CcSEcCtD
Rasagiline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000209	CcSEcCtD
Rasagiline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000208	CcSEcCtD
Rasagiline—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000207	CcSEcCtD
Rasagiline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000206	CcSEcCtD
Rasagiline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000205	CcSEcCtD
Rasagiline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000203	CcSEcCtD
Rasagiline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000202	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000201	CcSEcCtD
Rasagiline—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000199	CcSEcCtD
Rasagiline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000197	CcSEcCtD
Rasagiline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000195	CcSEcCtD
Rasagiline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000194	CcSEcCtD
Rasagiline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000192	CcSEcCtD
Rasagiline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000192	CcSEcCtD
Rasagiline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000192	CcSEcCtD
Rasagiline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000191	CcSEcCtD
Rasagiline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.00019	CcSEcCtD
Rasagiline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000187	CcSEcCtD
Rasagiline—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000186	CcSEcCtD
Rasagiline—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000185	CcSEcCtD
Rasagiline—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000184	CcSEcCtD
Rasagiline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000184	CcSEcCtD
Rasagiline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000184	CcSEcCtD
Rasagiline—BCL2—Immune System—ERBB2—peripheral nervous system neoplasm	0.0001	0.000536	CbGpPWpGaD
Rasagiline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000178	CcSEcCtD
Rasagiline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000176	CcSEcCtD
Rasagiline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	9.84e-05	0.000526	CbGpPWpGaD
Rasagiline—BCL2—Innate Immune System—HRAS—peripheral nervous system neoplasm	9.59e-05	0.000513	CbGpPWpGaD
Rasagiline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000172	CcSEcCtD
Rasagiline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	9.57e-05	0.000171	CcSEcCtD
Rasagiline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000171	CcSEcCtD
Rasagiline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.52e-05	0.000171	CcSEcCtD
Rasagiline—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000167	CcSEcCtD
Rasagiline—Pruritus—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000165	CcSEcCtD
Rasagiline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000159	CcSEcCtD
Rasagiline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.87e-05	0.000159	CcSEcCtD
Rasagiline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000155	CcSEcCtD
Rasagiline—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000154	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	8.56e-05	0.000458	CbGpPWpGaD
Rasagiline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000153	CcSEcCtD
Rasagiline—BCL2—Innate Immune System—AKT1—peripheral nervous system neoplasm	8.47e-05	0.000453	CbGpPWpGaD
Rasagiline—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000148	CcSEcCtD
Rasagiline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000148	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	8.21e-05	0.000439	CbGpPWpGaD
Rasagiline—Rash—Epirubicin—peripheral nervous system neoplasm	8.21e-05	0.000147	CcSEcCtD
Rasagiline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	8.2e-05	0.000147	CcSEcCtD
Rasagiline—Headache—Epirubicin—peripheral nervous system neoplasm	8.15e-05	0.000146	CcSEcCtD
Rasagiline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.96e-05	0.000143	CcSEcCtD
Rasagiline—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	7.9e-05	0.000422	CbGpPWpGaD
Rasagiline—Nausea—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000138	CcSEcCtD
Rasagiline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.66e-05	0.000137	CcSEcCtD
Rasagiline—BCL2—Immune System—NRAS—peripheral nervous system neoplasm	7.63e-05	0.000408	CbGpPWpGaD
Rasagiline—Rash—Doxorubicin—peripheral nervous system neoplasm	7.59e-05	0.000136	CcSEcCtD
Rasagiline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.58e-05	0.000136	CcSEcCtD
Rasagiline—Headache—Doxorubicin—peripheral nervous system neoplasm	7.54e-05	0.000135	CcSEcCtD
Rasagiline—Nausea—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000128	CcSEcCtD
Rasagiline—BCL2—Immune System—HRAS—peripheral nervous system neoplasm	5.58e-05	0.000299	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	5.19e-05	0.000277	CbGpPWpGaD
Rasagiline—BCL2—Immune System—AKT1—peripheral nervous system neoplasm	4.93e-05	0.000264	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	4.38e-05	0.000234	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.18e-05	0.000224	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	4.12e-05	0.00022	CbGpPWpGaD
Rasagiline—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	3.92e-05	0.00021	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	3.36e-05	0.00018	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	3.3e-05	0.000177	CbGpPWpGaD
Rasagiline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	9.08e-06	4.86e-05	CbGpPWpGaD
